Kathleen Gallagher

Corporate Officer/Principal bei AVIDITY BIOSCIENCES, INC.

Health Technology

Consumer Services

Aktive Positionen von Kathleen Gallagher

Unternehmen	Position	Beginn	Ende
AVIDITY BIOSCIENCES, INC.	Corporate Officer/Principal	-	-
	Investor Relations Kontakt	01.04.2021	-
	Public Communications Contact	01.04.2021	-

Unternehmen	Position	Beginn	Ende
MERRIMACK PHARMACEUTICALS, INC.	Public Communications Contact	01.01.2003	01.10.2016
AKCEA THERAPEUTICS, INC.	Investor Relations Kontakt	-	-
AKCEA THERAPEUTICS, INC.	Public Communications Contact	-	-

Boston University

Undergraduate Degree

International

Vereinigte Staaten	4
Israel	2

Operativ

Public Communications Contact	3
Investor Relations Contact	2
Undergraduate Degree	1

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
AVIDITY BIOSCIENCES, INC.	Health Technology

Private Unternehmen	2
Akcea Therapeutics, Inc. Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.	Health Technology
Merrimack Pharmaceuticals, Inc. Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.	Health Technology

Private Unternehmen

Health Technology